Ketogenic diet exposure during the juvenile period increases social behaviors and forebrain neural activation in adult Engrailed 2 null mice

Physiology and Behavior

Volumn 161, Issue , 2016, Pages 90-98

  Verpeut, Jessica L ^a   DiCicco Bloom, Emanuel ^b   Bello, Nicholas T ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Adolescence; Dopamine; Low carbohydrate diet; No carbohydrate diet; Nutrition therapy; Serotonin; Hydroxybutyrate

Indexed keywords

BRAIN MONOAMINE; CARBOHYDRATE; FAT; KETONE; NORADRENALIN; 3 HYDROXYBUTYRIC ACID; BIOGENIC AMINE; ENGRAILED 2 PROTEIN; HOMEODOMAIN PROTEIN; NERVE PROTEIN; PROTEIN C FOS;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTISM; BRAIN FUNCTION; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EXPLORATORY BEHAVIOR; FOREBRAIN; FRONTAL CORTEX; GROOMING; HIPPOCAMPUS; IMMUNOREACTIVITY; INTERVENTION STUDY; KETOGENIC DIET; MALE; MEDIOBASAL HYPOTHALAMUS; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; ONCOGENE C FOS; PERINATAL PERIOD; PRIORITY JOURNAL; SEPTUM NUCLEUS; SOCIAL BEHAVIOR; SOCIAL INTERACTION; STRIA TERMINALIS; WEANING; AGE; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; CYTOLOGY; DEFICIENCY; DIET THERAPY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

3-HYDROXYBUTYRIC ACID; AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; AUTISTIC DISORDER; BIOGENIC MONOAMINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; KETOGENIC DIET; MALE; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NEURONS; PROSENCEPHALON; PROTO-ONCOGENE PROTEINS C-FOS; SOCIAL BEHAVIOR;

EID: 84963805371     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2016.04.001     Document Type: Article

References (70)

1. Swink T.D., Vining E.P., Freeman J.M. The ketogenic diet: 1997. Adv. Pediatr. Infect. Dis. 1997, 44:297-329.
2. Kossoff E.H., Rho J.M. Ketogenic diets: evidence for short- and long-term efficacy. Neurotherapeutics 2009, 6:406-414.
3. Kossoff E.H., Zupec-Kania B.A., Rho J.M. Ketogenic diets: an update for child neurologists. J. Child Neurol. 2009, 24:979-988.
4. Lasser J.L., Brush M.K. An improved ketogenic diet for treatment of epilepsy. J. Am. Diet. Assoc. 1973, 62:281-285.
5. McNally M.A., Hartman A.L. Ketone bodies in epilepsy. J. Neurochem. 2012, 121:28-35.
6. Chmiel-Perzynska I., Kloc R., Perzynski A., Rudzki S., Urbanska E.M. Novel aspect of ketone action: beta-hydroxybutyrate increases brain synthesis of kynurenic acid in vitro. Neurotox. Res. 2011, 20:40-50.
7. Bough K.J., Wetherington J., Hassel B., Pare J.F., Gawryluk J.W., Greene J.G., Shaw R., Smith Y., Geiger J.D., Dingledine R.J. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 2006, 60:223-235.
8. Kim D.Y., Davis L.M., Sullivan P.G., Maalouf M., Simeone T.A., van Brederode J., Rho J.M. Ketone bodies are protective against oxidative stress in neocortical neurons. J. Neurochem. 2007, 101:1316-1326.
9. Kim D.Y., Hao J., Liu R., Turner G., Shi F.D., Rho J.M. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS One 2012, 7.
10. Maalouf M., Sullivan P.G., Davis L., Kim D.Y., Rho J.M. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 2007, 145:256-264.
11. Mi W., van Wijk N., Cansev M., Sijben J.W., Kamphuis P.J. Nutritional approaches in the risk reduction and management of Alzheimer's disease. Nutrition 2013, 29:1080-1089.
12. Richardson A.J. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot. Essent. Fat. Acids 2004, 70:383-390.
13. Stafstrom C.E., Rho J.M. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front. Pharmacol. 2012, 3:59.
14. Zukiewicz-Sobczak W., Krol R., Wroblewska P., Piatek J., Gibas-Dorna M. Huntington disease - principles and practice of nutritional management. Neurol. Neurochir. Pol. 2014, 48:442-448.
15. Opie R.S., Itsiopoulos C., Parletta N., Sanchez-Villegas A., Akbaraly T.N., Ruusunen A., Jacka F.N. Dietary recommendations for the prevention of depression. Nutr. Neurosci. 2015.
16. Zafeiriou D.I., Ververi A., Salomons G.S., Vargiami E., Haas D., Papadopoulou V., Kontopoulos E., Jakobs C. l-2-Hydroxyglutaric aciduria presenting with severe autistic features. Brain Dev. 2008, 30:305-307.
17. Zecavati N., Spence S.J. Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr. Neurol. Neurosci. Rep. 2009, 9:129-136.
18. Evangeliou A., Vlachonikolis I., Mihailidou H., Spilioti M., Skarpalezou A., Makaronas N., Prokopiou A., Christodoulou P., Liapi-Adamidou G., Helidonis E., Sbyrakis S., Smeitink J. Application of a ketogenic diet in children with autistic behavior: pilot study. J. Child Neurol. 2003, 18:113-118.
19. Lord C., Pickles A., McLennan J., Rutter M., Bregman J., Folstein S., Fombonne E., Leboyer M., Minshew N. Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J. Autism Dev. Disord. 1997, 27:501-517.
20. Deng W., Zou X., Deng H., Li J., Tang C., Wang X., Guo X. The relationship among genetic heritability, environmental effects, and autism spectrum disorders: 37 pairs of ascertained twin study. J. Child Neurol. 2015, 30:1794-1799.
21. Brune C.W., Korvatska E., Allen-Brady K., Cook E.H., Dawson G., Devlin B., Estes A., Hennelly M., Hyman S.L., McMahon W.M., Munson J., Rodier P.M., Schellenberg G.D., Stodgell C.J., Coon H. Heterogeneous association between engrailed-2 and autism in the CPEA network. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:187-193.
22. Wang L., Jia M., Yue W., Tang F., Qu M., Ruan Y., Lu T., Zhang H., Yan H., Liu J., Guo Y., Zhang J., Yang X., Zhang D. Association of the ENGRAILED 2 (EN2) gene with autism in Chinese Han population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:8-434.
23. Yang P., Lung F.W., Jong Y.J., Hsieh H.Y., Liang C.L., Juo S.H. Association of the homeobox transcription factor gene ENGRAILED 2 with autistic disorder in Chinese children. Neuropsychobiology 2008, 57:3-8.
24. Benayed R., Gharani N., Rossman I., Mancuso V., Lazar G., Kamdar S., Bruse S.E., Tischfield S., Smith B.J., Zimmerman R.A., Dicicco-Bloom E., Brzustowicz L.M., Millonig J.H. Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus. Am. J. Hum. Genet. 2005, 77:851-868.
25. Simon H.H., Scholz C., O'Leary D.D.M. Engrailed genes control developmental fate of serotonergic and noradrenergic neurons in mid- and hindbrain in a gene dose-dependent manner. Mol. Cell. Neurosci. 2005, 28:96-105.
26. Alberi L., Sgado P., Simon H.H. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development 2004, 131:3229-3236.
27. Gherbassi D., Simon H.H. The engrailed transcription factors and the mesencephalic dopaminergic neurons. J. Neural Transm. 2006, 47-55. (Supplementum).
28. Sgado P., Alberi L., Gherbassi D., Galasso S.L., Ramakers G.M., Alavian K.N., Smidt M.P., Dyck R.H., Simon H.H. Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15242-15247.
29. Halladay A.K., Amaral D., Aschner M., Bolivar V.J., Bowman A., DiCicco-Bloom E., Hyman S.L., Keller F., Lein P., Pessah I., Restifo L., Threadgill D.W. Animal models of autism spectrum disorders: information for neurotoxicologists. Neurotoxicology 2009, 30:811-821.
30. Loomis C.A., Harris E., Michaud J., Wurst W., Hanks M., Joyner A.L. The mouse Engrailed-1 gene and ventral limb patterning. Nature 1996, 382:360-363.
31. Hanks M.C., Loomis C.A., Harris E., Tong C.X., Anson-Cartwright L., Auerbach A., Joyner A. Drosophila engrailed can substitute for mouse Engrailed1 function in mid-hindbrain, but not limb development. Development 1998, 125:4521-4530.
32. Horikoshi M., Yamamoto T., Ohkuma Y., Weil P.A., Roeder R.G. Analysis of structure-function relationships of yeast TATA box binding factor TFIID. Cell 1990, 61:1171-1178.
33. Ohkuma Y., Horikoshi M., Roeder R.G., Desplan C. Engrailed, a homeodomain protein, can repress in vitro transcription by competition with the TATA box-binding protein transcription factor IID. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:2289-2293.
34. Jaynes J.B., O'Farrell P.H. Active repression of transcription by the engrailed homeodomain protein. EMBO J. 1991, 10:1427-1433.
35. Davidson D., Graham E., Sime C., Hill R. A gene with sequence similarity to Drosophila engrailed is expressed during the development of the neural tube and vertebrae in the mouse. Development 1988, 104:305-316.
36. Gardner C.A., Barald K.F. Expression patterns of engrailed-like proteins in the chick embryo. Dev. Dyn. 1992, 193:370-388.
37. Cheng Y., Sudarov A., Szulc K.U., Sgaier S.K., Stephen D., Turnbull D.H., Joyner A.L. The Engrailed homeobox genes determine the different foliation patterns in the vermis and hemispheres of the mammalian cerebellum. Development 2010, 137:519-529.
38. Genestine M., Lin L., Durens M., Yan Y., Jiang Y., Prem S., Bailoor K., Kelly B., Sonsalla P.K., Matteson P.G., Silverman J., Crawley J.N., Millonig J.H., DiCicco-Bloom E. Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior. Hum. Mol. Genet. 2015.
39. Fox S.R., Deneris E.S. Engrailed is required in maturing serotonin neurons to regulate the cytoarchitecture and survival of the dorsal raphe nucleus. J. Neurosci. 2012, 32:7832-7842.
40. Millen K.J., Wurst W., Herrup K., Joyner A.L. Abnormal embryonic cerebellar development and patterning of postnatal foliation in two mouse Engrailed-2 mutants. Development 1994, 120:695-706.
41. Kuemerle B., Zanjani H., Joyner A., Herrup K. Pattern deformities and cell loss in Engrailed-2 mutant mice suggest two separate patterning events during cerebellar development. J. Neurosci. 1997, 17:7881-7889.
42. Benayed R., Choi J., Matteson P.G., Gharani N., Kamdar S., Brzustowicz L.M., Millonig J.H. Autism-associated haplotype affects the regulation of the homeobox gene, ENGRAILED 2. Biol. Psychiatry 2009, 66:911-917.
43. Brielmaier J., Matteson P.G., Silverman J.L., Senerth J.M., Kelly S., Genestine M., Millonig J.H., DiCicco-Bloom E., Crawley J.N. Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice. PLoS One 2012, 7.
44. Cheh M.A., Millonig J.H., Roselli L.M., Ming X., Jacobsen E., Kamdar S., Wagner G.C. En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder. Brain Res. 2006, 1116:166-176.
45. Vogel M.W., Ji Z.Q., Millen K., Joyner A.L. The Engrailed-2 homeobox gene and patterning of spinocerebellar mossy fiber afferents. Dev. Brain Res. 1996, 96:210-218.
46. Joyner A.L., Herrup K., Auerbach B.A., Davis C.A., Rossant J. Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox. Science 1991, 251:1239-1243.
47. Sgado P., Genovesi S., Kalinovsky A., Zunino G., Macchi F., Allegra M., Murenu E., Provenzano G., Tripathi P.P., Casarosa S., Joyner A.L., Bozzi Y. Loss of GABAergic neurons in the hippocampus and cerebral cortex of Engrailed-2 null mutant mice: implications for autism spectrum disorders. Exp. Neurol. 2013, 247:496-505.
48. Rossman I.T., Lin L., Morgan K.M., Digiovine M., Van Buskirk E.K., Kamdar S., Millonig J.H., Dicicco-Bloom E. Engrailed2 modulates cerebellar granule neuron precursor proliferation, differentiation and insulin-like growth factor 1 signaling during postnatal development. Mol. Autism 2014, 5:9.
49. Provenzano G., Pangrazzi L., Poli A., Pernigo M., Sgado P., Genovesi S., Zunino G., Berardi N., Casarosa S., Bozzi Y. Hippocampal dysregulation of neurofibromin-dependent pathways is associated with impaired spatial learning in engrailed 2 knock-out mice. J. Neurosci. 2014, 34:13281-13288.
50. Kanner L. Autistic disturbances of affective contact. Acta Paedopsychiatr. 1968, 35:100-136.
51. Baio J. Prevalence of autism spectrum disorder among children aged 8 years - Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2010. MMWR Surveill. Summ. 2014, 63:21p.
52. Choi J., Ababon M.R., Soliman M., Lin Y., Brzustowicz L.M., Matteson P.G., Millonig J.H. Autism associated gene, engrailed2, and flanking gene levels are altered in post-mortem cerebellum. PLoS One 2012, 9.
53. James S.J., Shpyleva S., Melnyk S., Pavliv O., Pogribny I.P. Complex epigenetic regulation of engrailed-2 (EN-2) homeobox gene in the autism cerebellum. Transl. Psychiatry 2013, 3.
54. Zhong H., Serajee F.J., Nabi R., Huq A.H. No association between the EN2 gene and autistic disorder. J. Med. Genet. 2003, 40.
55. Shimizu H., Fisler S., Bray G.A. Extracellular hypothalamic monoamines measured by in vivo microdialysis in a rat model of dietary fat-induced obesity. Obes. Res. 1994, 2:100-109.
56. Mosek A., Natour H., Neufeld M.Y., Shiff Y., Vaisman N. Ketogenic diet treatment in adults with refractory epilepsy: a prospective pilot study. Seizure 2009, 18:30-33.
57. Joyner A.L., Skarnes W.C., Rossant J. Production of a mutation in mouse En-2 gene by homologous recombination in embryonic stem cells. Nature 1989, 338:153-156.
58. Joyner A.L. Engrailed, Wnt and Pax genes regulate midbrain-hindbrain development. Trends Genet. 1996, 12:15-20.
59. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, Academic Press. Compact 3rd ed.
60. Verpeut J.L., Walters A.L., Bello N.T. Citrus aurantium and Rhodiola rosea in combination reduce visceral white adipose tissue and increase hypothalamic norepinephrine in a rat model of diet-induced obesity. Nutr. Res. 2013, 33:503-512.
61. Bisler S., Schleicher A., Gass P., Stehle J.H., Zilles K., Staiger J.F. Expression of c-Fos, ICER, Krox-24 and JunB in the whisker-to-barrel pathway of rats: time course of induction upon whisker stimulation by tactile exploration of an enriched environment. J. Chem. Neuroanat. 2002, 23:187-198.
62. Bello N.T., Walters A.L., Verpeut J.L., Cunha P.P. High-fat diet-induced alterations in the feeding suppression of low-dose nisoxetine, a selective norepinephrine reuptake inhibitor. J. Obes. 2013, 2013:457047.
63. Genestine M., Lin L., Durens M., Yan Y., Jiang Y., Prem S., Bailoor K., Kelly B., Sonsalla P.K., Matteson P.G., Silverman J., Crawley J.N., Millonig J.H., DiCicco-Bloom E. Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior. Hum. Mol. Genet. 2015, 24:5805-5827.
64. Del Rio D., Cano V., Martin-Ramos M., Gomez M., Morales L., Del Olmo N., Ruiz-Gayo M. Involvement of the dorsomedial prefrontal cortex in high-fat food conditioning in adolescent mice. Behav. Brain Res. 2015, 283:227-232.
65. Gugusheff J.R., Ong Z.Y., Muhlhausler B.S. The early origins of food preferences: targeting the critical windows of development. FASEB J. 2015, 29:365-373.
66. Szot P., Weinshenker D., Rho J.M., Storey T.W., Schwartzkroin P.A. Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Brain Res. Dev. Brain Res. 2001, 129:211-214.
67. Weinshenker D. The contribution of norepinephrine and orexigenic neuropeptides to the anticonvulsant effect of the ketogenic diet. Epilepsia 2008, 49(Suppl. 8):104-107.
68. Fatemi S.H., Aldinger K.A., Ashwood P., Bauman M.L., Blaha C.D., Blatt G.J., Chauhan A., Chauhan V., Dager S.R., Dickson P.E., Estes A.M., Goldowitz D., Heck D.H., Kemper T.L., King B.H., Martin L.A., Millen K.J., Mittleman G., Mosconi M.W., Persico A.M., Sweeney J.A., Webb S.J., Welsh J.P. Consensus paper: pathological role of the cerebellum in autism. Cerebellum 2012, 11:777-807.
69. Ruskin D.N., Svedova J., Cote J.L., Sandau U., Rho J.M., Kawamura M., Boison D., Masino S.A. Ketogenic diet improves core symptoms of autism in BTBR mice. PLoS One 2013, 8.
70. Zilkha N., Kuperman Y., Kimchi T. High-fat diet exacerbates cognitive rigidity and social deficiency in the BTBR mouse model of autism. Neuroscience 2016.